Hyperkalaemia: Emergency Recognition and Management Principles

An updated guide to hyperkalaemia severity, ECG assessment, cardiac protection, intracellular shift, potassium removal and monitoring.

Clinical ID: LIB-000000019 Version: 1.0 Evidence: Evidence-informed Reading time: 3 minutes

Clinical overview

Hyperkalaemia can cause fatal arrhythmia and requires rapid assessment of severity, ECG findings, underlying cause and likelihood of further rise. Management has three parallel aims: protect the myocardium when indicated, shift potassium into cells and remove potassium from the body.

Why this matters in practice

Hyperkalaemia: Emergency Recognition and Management Principles should be interpreted as part of a structured clinical assessment. The numerical result, symptom burden, rate of change, comorbidity, medicines and response to treatment all influence risk. A single threshold can support a decision, but it should not override clear evidence of physiological deterioration.

Physiology and pathophysiology

Raised extracellular potassium reduces the resting membrane potential and can impair conduction. Risk is influenced by concentration, rate of rise, calcium status, acid-base state, kidney function and coexisting cardiac disease.

Measurement and pre-analytical checks

Confirm patient identity, specimen timing, units and the laboratory method. Review haemolysis, contamination, transport delay, sampling from an infusion line and other pre-analytical factors when the result is unexpected. Compare with previous measurements from the same laboratory where possible, because reference intervals and assay behaviour can differ.

Structured clinical assessment

Obtain urgent ECG monitoring, repeat the sample if pseudohyperkalaemia is plausible without delaying treatment in a high-risk patient, stop avoidable potassium sources and contributing medicines, and follow the local hyperkalaemia pathway. Recheck potassium and glucose at protocol-defined intervals because rebound and treatment-related hypoglycaemia can occur.

Interpretation in context

Interpret the value alongside observations, examination, fluid status, renal and liver function, acid-base data, medicines and relevant imaging or microbiology. Trend is often more informative than a single measurement. A modest abnormality that is changing rapidly may be more important than a stable, longstanding result outside the reference interval.

Special populations

Reference intervals and diagnostic performance may differ in pregnancy, children, older adults, critical illness, advanced kidney or liver disease and people with unusual body composition. Use population-specific guidance and specialist advice where the ordinary interpretation is unreliable. Do not transfer adult thresholds directly to paediatric or obstetric care.

Common pitfalls

Calcium protects the heart but does not lower serum potassium. Insulin lowers potassium but can cause delayed hypoglycaemia. Nebulised beta-agonist response is variable and should not be used as sole therapy in severe cases. Dialysis may be required when medical treatment is ineffective or kidney failure is advanced.

Red flags and escalation

ECG change, potassium in the severe range, cardiac arrest, profound weakness, rapidly worsening kidney function or ongoing tissue breakdown requires immediate senior, critical care and renal involvement.

Monitoring and follow-up

Set the repeat-testing interval according to clinical risk and the expected speed of change. Document the value, interpretation, action and follow-up plan. After treatment, confirm both biochemical and clinical response and watch for rebound, overcorrection or treatment-related complications.

Communication and handover

Communicate the actual result, units, relevant reference interval, trend and working interpretation. State what has been done, what remains uncertain and which finding should trigger escalation. Avoid vague shorthand when a result has direct implications for medicines, monitoring or level of care.

Frequently asked questions

Can one result establish the diagnosis?

No. Most abnormalities require confirmation, context and a review of trend, symptoms and potential confounders.

Should treatment aim only to normalise the number?

No. Treatment should address the underlying mechanism and improve patient-centred outcomes while avoiding complications of overcorrection.

When should specialist advice be requested?

Seek advice when the abnormality is severe, rapidly changing, unexplained, treatment-resistant, associated with organ dysfunction or outside the population in which the usual pathway is validated.

Key points for practice

  • Confirm the result and the clinical context before acting.
  • Assess severity, symptoms and rate of change.
  • Review medicines, comorbidity and reversible causes.
  • Use local protocols and population-specific guidance.
  • Trend the response and document a clear follow-up plan.
  • Escalate physiological deterioration regardless of a reassuring isolated number.

References and further reading

  1. UK Kidney Association 2023 Hyperkalaemia Guideline
  2. NICE BNF treatment summary: Hyperkalaemia
  3. MHRA Drug Safety Update: Calcium gluconate and calcium chloride
Reviewed by: MedicalC Clinical Editorial Team Last reviewed: 2026-08-04 Next review: 2028-08-04
This professional reference supports education and clinical decision-making. It does not replace local policy, specialist advice or individual clinical judgement.